Clinical trials sponsored by Boryung Pharmaceutical Co., Ltd

Phase breakdown

Conditions studied

Recruiting trials led by Boryung Pharmaceutical Co., Ltd

• A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
  NCT06821945 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
  NCT06126016 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
  NCT06972732 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Study of Olanzapine in Participants With Bipolar Disorder.
  NCT07263191 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
  NCT07263178 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
  NCT05970237 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
  NCT06314919 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
  NCT06649162 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
  NCT05413057 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Boryung Pharmaceutical Co., Ltd recruiting for?

Boryung Pharmaceutical Co., Ltd is the lead sponsor of 9 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.